Andre Jacques Auberton Herve Bionik Laboratories Corp. (BNKL) insider trading activity

Andre Jacques Auberton Herve is Director of Bionik Laboratories Corp.. Currently has a direct ownership of 95,149 shares of BNKL, which is worth approximately $0. The most recent transaction as insider was on Mar 26, 2021, when has been sold 95,149 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).